Jill Broadfoot - ATyr Pharma, Chief Officer

ATyr Pharma, Management Efficiency

The company has return on total asset (ROA) of (0.3274) % which means that it has lost $0.3274 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6176) %, meaning that it created substantial loss on money invested by shareholders. ATyr Pharma,'s management efficiency ratios could be used to measure how well ATyr Pharma, manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/25/2024, Return On Tangible Assets is likely to drop to -0.43. In addition to that, Return On Capital Employed is likely to drop to -0.55. At this time, ATyr Pharma,'s Other Current Assets are relatively stable compared to the past year. As of 11/25/2024, Non Currrent Assets Other is likely to grow to about 139 K, while Total Assets are likely to drop slightly above 102.3 M.

Similar Executives

aTyr Pharma, (ATYR) is traded on NASDAQ Exchange in USA. It is located in 10240 Sorrento Valley Road, San Diego, CA, United States, 92121 and employs 56 people. aTyr Pharma, was previously known as ATyr Pharma and was traded on NASDAQ Exchange under the symbol LIFE. ATyr Pharma, is listed under Biotechnology category by Fama And French industry classification.

Management Performance

aTyr Pharma, Leadership Team

ATyr Stock Performance Indicators

Pair Trading with ATyr Pharma,

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ATyr Pharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma, will appreciate offsetting losses from the drop in the long position's value.

Additional Tools for ATyr Stock Analysis